Linscomb & Williams, Inc. Amgen Inc Transaction History

Linscomb & Williams, Inc.

$2.01 Billion
Q3 2024

A detailed history of Linscomb & Williams, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 33,547 shares of AMGN stock, worth $9.57 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

33,547

Previous 34,031 1.42%

Holding current value

$9.57 Million

Previous $10.6 Million 1.66%

% of portfolio

0.54%

Previous 0.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$309.38 - $337.38 $149,739 - $163,291	-484 Reduced 1.42%	33,547 $10.8 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $191,544 - $232,776	-729 Reduced 2.1%	34,031 $10.6 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $146,803 - $177,209	-546 Reduced 1.55%	34,760 $9.88 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $983,422 - $1.11 Million	-3,846 Reduced 9.82%	35,306 $10.2 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $667,319 - $828,495	-3,052 Reduced 7.23%	39,152 $10.5 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $424,254 - $501,672	-1,980 Reduced 4.48%	42,204 $9.37 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $193,276 - $235,571	-856 Reduced 1.9%	44,184 $10.7 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $76,037 - $96,615	332 Added 0.74%	45,040 $11.8 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $172,834 - $194,925	770 Added 1.75%	44,708 $10.1 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $158,267 - $176,123	686 Added 1.59%	43,938 $10.7 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $501,251 - $554,515	2,286 Added 5.58%	43,252 $10.5 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $203,255 - $232,607	1,022 Added 2.56%	40,966 $9.22 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $258,969 - $303,414	1,220 Added 3.15%	39,944 $8.49 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $347,800 - $385,859	1,489 Added 4.0%	38,724 $9.44 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $272,061 - $317,043	1,226 Added 3.4%	37,235 $9.26 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $176,349 - $210,001	815 Added 2.32%	36,009 $8.28 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $181,384 - $201,714	773 Added 2.25%	35,194 $8.95 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $766,118 - $940,132	3,873 Added 12.68%	34,421 $8.12 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $321,471 - $426,358	1,764 Added 6.13%	30,548 $6.19 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $204,157 - $262,412	1,079 Added 3.89%	28,784 $6.94 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $217,289 - $260,357	1,248 Added 4.72%	27,705 $5.36 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $97,352 - $114,119	584 Added 2.26%	26,457 $4.88 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $80,306 - $90,522	444 Added 1.75%	25,873 $4.92 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $76,355 - $89,131	428 Added 1.71%	25,429 $4.95 Million
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $67,630 - $76,244	365 Added 1.48%	25,001 $5.18 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $167,710 - $188,375	1,010 Added 4.27%	24,636 $4.55 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $31,175 - $36,432	184 Added 0.78%	23,626 $4.03 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $100,598 - $112,399	596 Added 2.61%	23,442 $4.08 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $3.82 Million - $4.36 Million	22,846	22,846 $4.26 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Account

Linscomb & Williams, Inc. Amgen Inc Transaction History